Search Results - "Stauber, Rudolf E"

Refine Results
  1. 1

    Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both? by Staufer, Katharina, Stauber, Rudolf E

    Published in Biomedicines (26-07-2023)
    “…Non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD), both of them accounting for fatty liver disease (FLD), are among the most…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Oxidative albumin damage in chronic liver failure: Relation to albumin binding capacity, liver dysfunction and survival by Oettl, Karl, Birner-Gruenberger, Ruth, Spindelboeck, Walter, Stueger, Hans Peter, Dorn, Livia, Stadlbauer, Vanessa, Putz-Bankuti, Csilla, Krisper, Peter, Graziadei, Ivo, Vogel, Wolfgang, Lackner, Carolin, Stauber, Rudolf E

    Published in Journal of hepatology (01-11-2013)
    “…Background & Aims Impaired binding function of albumin has been demonstrated in end-stage liver disease. This and other functional disturbances of albumin may…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C by LACKNER, Carolin, STRUBER, Gerd, LIEGL, Bernadette, LEIBL, Sebastian, OFNER, Petra, BANKUTI, Csilla, BAUER, Bernd, STAUBER, Rudolf E

    Published in Hepatology (Baltimore, Md.) (01-06-2005)
    “…Liver biopsy is recommended before antiviral treatment, particularly for patients with hepatitis C virus (HCV) genotype 1 infection, but it may cause…”
    Get full text
    Journal Article
  7. 7

    Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C by Stauber, Rudolf-E, Lackner, Carolin

    Published in World journal of gastroenterology : WJG (28-08-2007)
    “…Assessment of hepatic fibrosis is important for determining prognosis, guiding management decisions, and monitoring disease. Histological evaluation of liver…”
    Get full text
    Journal Article
  8. 8

    Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke by Fandler-Höfler, Simon, Stauber, Rudolf E., Kneihsl, Markus, Wünsch, Gerit, Haidegger, Melanie, Poltrum, Birgit, Pichler, Alexander, Deutschmann, Hannes, Enzinger, Christian, Fickert, Peter, Gattringer, Thomas

    “…Background: Liver fibrosis has been identified as an outcome predictor in cardiovascular disease and has been associated with hematoma expansion and mortality…”
    Get full text
    Journal Article
  9. 9

    Albumin in patients with liver disease shows an altered conformation by Paar, Margret, Fengler, Vera H., Rosenberg, Daniel J., Krebs, Angelika, Stauber, Rudolf E., Oettl, Karl, Hammel, Michal

    Published in Communications biology (14-06-2021)
    “…Human serum albumin (HSA) constitutes the primary transporter of fatty acids, bilirubin, and other plasma compounds. The binding, transport, and release of its…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Hepatotoxicity of NONI juice: Report of two cases by Stadlbauer, Vanessa, Fickert, Peter, Lackner, Carolin, Schmerlaib, Jutta, Krisper, Peter, Trauner, Michael, Stauber, Rudolf E

    Published in World journal of gastroenterology : WJG (14-08-2005)
    “…NONI juice (Morinda citrifolia) is an increasingly popular wellness drink claimed to be beneficial for many illnesses. No overt toxicity has been reported to…”
    Get full text
    Journal Article
  12. 12

    Human Nonmercaptalbumin-2: A Novel Prognostic Marker in Chronic Liver Failure by Stauber, Rudolf E., Spindelboeck, Walter, Haas, Josef, Putz-Bankuti, Csilla, Stadlbauer, Vanessa, Lackner, Carolin, Oettl, Karl

    Published in Therapeutic apheresis and dialysis (01-02-2014)
    “…Albumin is the major plasma protein with several important biological functions. Various disturbances of albumin function have been demonstrated in end‐stage…”
    Get full text
    Journal Article
  13. 13

    Fibroscan® probe selection for lean adults by Stadlbauer, Vanessa, Negrean, Iohanes, Posch, Andreas, Streit, Andrea, Feldbacher, Nicole, Stauber, Rudolf E, Horvath, Angela

    Published in JGH open (01-07-2021)
    “…Background and Aim Fibroscan® is used to assess fibrosis and steatosis of the liver noninvasively. The company suggests to use the S+‐probe in people <18 years…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    HSD17B13 truncated variant is associated with a mild hepatic phenotype in Wilson’s Disease by Ferenci, Peter, Pfeiffenberger, Jan, Stättermayer, Albert Friedrich, Stauber, Rudolf E., Willheim, Claudia, Weiss, Karl H., Munda-Steindl, Petra, Trauner, Michael, Schilsky, Michael, Zoller, Heinz

    Published in JHEP reports (01-05-2019)
    “…HSD17B13 encodes hydroxysteroid 17-β dehydrogenase 13, a novel liver lipid-droplet associated protein that is involved in the regulation of lipid biosynthetic…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Severe toxic hepatitis associated with dronedarone by Jahn, Stephan, Zollner, Gernot, Lackner, Carolin, Stauber, Rudolf E

    Published in Current drug safety (01-07-2013)
    “…Dronedarone was introduced in 2009 as a new antiarrhythmic agent and since then has been increasingly prescribed in atrial fibrillation or flutter. To date,…”
    Get more information
    Journal Article
  19. 19
  20. 20